# Cognitive Behavioral Therapy Following Esketamine for Major Depression and Suicidal Ideation for Relapse Prevention

> **NCT04760652** · NA · COMPLETED · sponsor: **Yale University** · enrollment: 92 (actual)

## Conditions studied

- Depression and Suicide

## Interventions

- **BEHAVIORAL:** Cognitive Behavioral Therapy CBT

## Key facts

- **NCT ID:** NCT04760652
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-05
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-06-30
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2025-07-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04760652

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04760652, "Cognitive Behavioral Therapy Following Esketamine for Major Depression and Suicidal Ideation for Relapse Prevention". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT04760652. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*